Published in JAMA on June 15, 1994
Human papillomavirus and cervical cancer. Clin Microbiol Rev (2003) 3.90
Comparison of linear array and line blot assay for detection of human papillomavirus and diagnosis of cervical precancer and cancer in the atypical squamous cell of undetermined significance and low-grade squamous intraepithelial lesion triage study. J Clin Microbiol (2007) 2.27
Papanicolaou test screening and prevalence of genital human papillomavirus among women who have sex with women. Am J Public Health (2001) 1.93
PCR based high risk HPV testing is superior to neural network based screening for predicting incident CIN III in women with normal cytology and borderline changes. J Clin Pathol (2000) 1.73
Prevalence of risk factors associated with human papillomavirus infection in women living with HIV. Canadian Women's HIV Study Group. CMAJ (1999) 1.63
Immunization with a pentameric L1 fusion protein protects against papillomavirus infection. J Virol (2001) 1.55
Inadequate follow-up for abnormal Pap smears in an urban population. J Natl Med Assoc (2003) 1.49
Triage of women with equivocal or low-grade cervical cytology results: a meta-analysis of the HPV test positivity rate. J Cell Mol Med (2009) 1.48
Comparison of the hybrid capture tube test and PCR for detection of human papillomavirus DNA in cervical specimens. J Clin Microbiol (1997) 1.44
Five-year experience of human papillomavirus DNA and Papanicolaou test cotesting. Obstet Gynecol (2009) 1.41
Early natural history of incident, type-specific human papillomavirus infections in newly sexually active young women. Cancer Epidemiol Biomarkers Prev (2010) 1.21
Age-appropriate use of human papillomavirus vaccines in the U.S. Gynecol Oncol (2009) 1.16
Collection of cervical secretions does not adversely affect Pap smears taken immediately afterward. Clin Diagn Lab Immunol (1998) 1.14
Quantitative human papillomavirus 16 and 18 levels in incident infections and cervical lesion development. J Med Virol (2009) 1.06
Rapid rise in detection of human papillomavirus (HPV) infection soon after incident HIV infection among South African women. J Infect Dis (2011) 1.04
Preferences for human papillomavirus testing with routine cervical cancer screening in diverse older women. J Gen Intern Med (2008) 1.03
Preventive healthcare for underserved women: results of a prison survey. J Womens Health (Larchmt) (2010) 1.01
Accuracy of optical spectroscopy for the detection of cervical intraepithelial neoplasia: Testing a device as an adjunct to colposcopy. Int J Cancer (2010) 1.00
Study of viral integration of HPV-16 in young patients with LSIL. J Clin Pathol (2003) 1.00
Non-progression of cervical intraepithelial neoplasia estimated from population-screening data. Br J Cancer (1997) 1.00
Timeliness of cervical cancer diagnosis and initiation of treatment in the National Breast and Cervical Cancer Early Detection Program. J Womens Health (Larchmt) (2012) 0.98
Oncogenic human papillomavirus DNA loads in human immunodeficiency virus-positive women with high-grade cervical lesions are strongly elevated. J Clin Microbiol (2003) 0.95
Variations in practice guideline adherence for abnormal cervical cytology in a county healthcare system. J Gen Intern Med (2008) 0.94
Serological detection of human papillomavirus type 16 infection in human immunodeficiency virus (HIV)-positive and high-risk HIV-negative women. Clin Vaccine Immunol (2006) 0.93
2001 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus. Infect Dis Obstet Gynecol (2002) 0.90
Role of the vaginal microbiological ecosystem and cytokine profile in the promotion of cervical dysplasia: a case-control study. Infect Dis Obstet Gynecol (2002) 0.88
Role of nuclear progesterone receptor isoforms in uterine pathophysiology. Hum Reprod Update (2014) 0.87
HPV prevalence and genetic predisposition to cervical cancer in Saudi Arabia. Infect Agent Cancer (2013) 0.87
Effectiveness of follow up-letters to health care providers in triggering follow-up for women with abnormal results on Papanicolaou testing. CMAJ (2001) 0.86
HPV Infection in Cervical and Other Cancers in Saudi Arabia: Implication for Prevention and Vaccination. Front Oncol (2014) 0.85
Telomerase activity as an adjunct to high-risk human papillomavirus types 16 and 18 and cytology screening in cervical cancer. Br J Cancer (2006) 0.84
Measurements of human papillomavirus transcripts by real time quantitative reverse transcription-polymerase chain reaction in samples collected for cervical cancer screening. J Mol Diagn (2002) 0.84
Molecular tests for human papillomavirus (HPV), Chlamydia trachomatis and Neisseria gonorrhoeae in liquid-based cytology specimen. BMC Womens Health (2009) 0.84
Cervical cancer: developments in screening and evaluation of the abnormal Pap smear. West J Med (1998) 0.81
Effectiveness of screening for cervical cancer in an inpatient hospital setting. Obstet Gynecol (2004) 0.81
Incident anal human papillomavirus and human papillomavirus-related sequelae in HIV-infected versus HIV-uninfected adolescents in the United States. Sex Transm Dis (2013) 0.78
Evaluation of atypical squamous cells on conventional cytology smears: An experience from a screening program practiced in limited resource settings. Cytojournal (2010) 0.78
Plasma proteomic analysis of patients with squamous cell carcinoma of the uterine cervix. J Gynecol Oncol (2008) 0.77
Application of bethesda system for cervical cytology in unhealthy cervix. J Clin Diagn Res (2014) 0.76
Cervical cytology and colposcopy in clinics for sexually transmitted diseases--when are they appropriate? Genitourin Med (1996) 0.75
Cervical pathology--the Bethesda System and the 'atypical squamous cells of undetermined significance' controversy. West J Med (1995) 0.75
Histologic correlates of glandular abnormalities in cervical cytology among women with human immunodeficiency virus. Obstet Gynecol (2009) 0.75
Pap test results. Responding to Bethesda system reports. Can Fam Physician (2001) 0.75
Analysis of Sensitivity, Specificity, and Positive and Negative Predictive Values of Smear and Colposcopy in Diagnosis of Premalignant and Malignant Cervical Lesions. Med Sci Monit (2015) 0.75
Predisposition to Cervical Atypia in Systemic Lupus Erythematosus: A Clinical and Cytopathological Study. Autoimmune Dis (2015) 0.75
Can 2009 herald a new era in preventing cervical cancers? J Carcinog (2009) 0.75
1999 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus. U.S. Public Health Service (USPHS) and Infectious Diseases Society of America (IDSA). Infect Dis Obstet Gynecol (2000) 0.75
A feasibility study to identify proteins in the residual Pap test fluid of women with normal cytology by mass spectrometry-based proteomics. Clin Proteomics (2014) 0.75
Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J Natl Cancer Inst (1995) 18.86
Adenocarcinoma of the vagina. Association of maternal stilbestrol therapy with tumor appearance in young women. N Engl J Med (1971) 11.95
Improved amplification of genital human papillomaviruses. J Clin Microbiol (2000) 11.50
Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases. Cancer (1989) 8.07
Persistence of type-specific human papillomavirus infection among cytologically normal women. J Infect Dis (1994) 7.00
Prognostic factors in colorectal cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med (2000) 5.68
A National Cancer Institute Workshop on Hereditary Nonpolyposis Colorectal Cancer Syndrome: meeting highlights and Bethesda guidelines. J Natl Cancer Inst (1997) 5.68
Determinants of genital human papillomavirus infection in young women. J Natl Cancer Inst (1991) 4.14
Design and methods of a population-based natural history study of cervical neoplasia in a rural province of Costa Rica: the Guanacaste Project. Rev Panam Salud Publica (1997) 3.67
Human papillomavirus testing by hybrid capture appears to be useful in triaging women with a cytologic diagnosis of atypical squamous cells of undetermined significance. Am J Obstet Gynecol (1995) 3.59
Liver, gallbladder, extrahepatic bile ducts, and pancreas. Cancer (1995) 3.01
A comparison of pregnancy history recall and medical records. Implications for retrospective studies. Am J Epidemiol (1985) 2.65
Adenocarcinoma of the vagina in adolescence. A report of 7 cases including 6 clear-cell carcinomas (so-called mesonephromas). Cancer (1970) 2.44
Benign breast changes and the risk for subsequent breast cancer: an update of the 1985 consensus statement. Cancer Committee of the College of American Pathologists. Arch Pathol Lab Med (1998) 2.38
Three solutions to problems of categorized medical nomenclatures. Methods Inf Med (1984) 2.36
Conditional survival among patients with carcinoma of the lung. Chest (1999) 2.30
Evaluation of seroreactivity to human papillomavirus type 16 virus-like particles in an incident case-control study of cervical neoplasia. J Infect Dis (1995) 2.21
Clear-cell adenocarcinoma of the genital tract in young females. Registry report. N Engl J Med (1972) 2.11
Avoiding serious infections associated with abdominal hysterectomy: a meta-analysis of antibiotic prophylaxis. Am J Obstet Gynecol (1993) 2.07
Toward objective quality assurance in cervical cytopathology. Correlation of cytopathologic diagnoses with detection of high-risk human papillomavirus types. Am J Clin Pathol (1994) 2.00
A twenty-five-year follow-up study of women exposed to diethylstilbestrol during pregnancy. N Engl J Med (1978) 1.95
Artificial neural networks improve the accuracy of cancer survival prediction. Cancer (1997) 1.91
Revisiting the autopsy. Arch Pathol Lab Med (1990) 1.73
Determinants of genital human papillomavirus infection in low-risk women in Portland, Oregon. Sex Transm Dis (1993) 1.72
New epidemiology of human papillomavirus infection and cervical neoplasia. J Natl Cancer Inst (1995) 1.71
Human papillomavirus and cervical neoplasia: a case-control study in Taiwan. Int J Cancer (1995) 1.66
Epidemiology and partial nucleotide sequence of four novel genital human papillomaviruses. J Infect Dis (1994) 1.64
Delayed hypersensitivity in Graves' disease and exophthalmos: identification of thyroglobulin in normal human orbital muscle. Endocrinology (1977) 1.64
Conditional survival estimates in 34,963 patients with invasive carcinoma of the colon. Dis Colon Rectum (1998) 1.61
Updated protocol for the examination of specimens removed from patients with colorectal carcinoma. A basis for checklists. Arch Pathol Lab Med (1997) 1.58
Age-incidence and risk of diethylstilbestrol-related clear cell adenocarcinoma of the vagina and cervix. Am J Obstet Gynecol (1977) 1.57
Bowel perforation with suprapubic cystostomy Report of two cases. Obstet Gynecol (1976) 1.54
Risk factors for the development of diethylstilbestrol-associated clear cell adenocarcinoma: a case-control study. Am J Obstet Gynecol (1986) 1.54
Loss of p53-immunostaining intensity in breast cancer. J Natl Cancer Inst (1996) 1.53
Analysis of individual human papillomavirus types in cervical neoplasia: a possible role for type 18 in rapid progression. Am J Obstet Gynecol (1988) 1.52
Epidemiology of vaginal adenosis and adenocarcinoma associated with exposure to stilbestrol in utero. Cancer (1977) 1.51
Molecular diagnosis of genital human papillomavirus infection: comparison of two methods used to collect exfoliated cervical cells. Am J Obstet Gynecol (1989) 1.51
Determinants of genital human papillomavirus infection in low-income women in Washington, D.C. Sex Transm Dis (1993) 1.48
Terminology of endocrine tumors of the uterine cervix: results of a workshop sponsored by the College of American Pathologists and the National Cancer Institute. Arch Pathol Lab Med (1997) 1.48
Incidence and survival trends of esophageal carcinoma in the United States: racial and gender differences by histological type. Scand J Gastroenterol (2002) 1.44
Comparison of the hybrid capture tube test and PCR for detection of human papillomavirus DNA in cervical specimens. J Clin Microbiol (1997) 1.44
Interleukin 2 production in vitro by peripheral lymphocytes in response to human papillomavirus-derived peptides: correlation with cervical pathology. Cancer Res (1996) 1.39
Changing the rules of colposcopy. Gynecol Oncol (1994) 1.39
Is the meaning of science changing in the practice of medicine? Mod Pathol (1996) 1.37
Clear-cell adenocarcinoma of the vagina and cervix in girls: analysis of 170 registry cases. Am J Obstet Gynecol (1974) 1.33
History and international developments in cancer staging. Cancer Prev Control (1998) 1.32
Cancer risk in women exposed to diethylstilbestrol in utero. JAMA (1998) 1.32
Basaloid and warty carcinomas of the vulva. Distinctive types of squamous cell carcinoma frequently associated with human papillomaviruses. Am J Surg Pathol (1993) 1.31
Cancer risk in men exposed in utero to diethylstilbestrol. J Natl Cancer Inst (2001) 1.30
Vaginal and cervical abnormalities after exposure to stilbestrol in utero. Obstet Gynecol (1972) 1.29
Inter-laboratory variation as an explanation for varying prevalence estimates of human papillomavirus infection. Int J Cancer (1989) 1.27
Immunohistochemical assessment of estrogen receptor distribution in the human endometrium throughout the menstrual cycle. Lab Invest (1984) 1.27
Structural anomalies of the cervix and vagina in women enrolled in the Diethylstilbestrol Adenosis (DESAD) Project. Am J Obstet Gynecol (1984) 1.27
Diethylstilbestrol usage: Its interesting past, important present, and questionable future. Med Clin North Am (1974) 1.26
Unusual types of gallbladder carcinoma. A report of 16 cases. Arch Pathol Lab Med (1981) 1.25
Environmental endocrine modulators and human health: an assessment of the biological evidence. Crit Rev Toxicol (1998) 1.25
Biomarkers for early detection of colon cancer. Clin Cancer Res (2001) 1.23
Fertility in men exposed prenatally to diethylstilbestrol. N Engl J Med (1995) 1.22
Biochemical epidemiology of cervical neoplasia: measuring cigarette smoke constituents in the cervix. Cancer Res (1987) 1.21
Reproductive and gynecologic surgical experience in diethylstilbestrol-exposed daughters. Am J Obstet Gynecol (1981) 1.19
Long-term cancer risk in women given diethylstilbestrol (DES) during pregnancy. Br J Cancer (2001) 1.19
Fertility and outcome of pregnancy in women exposed in utero to diethylstilbestrol. N Engl J Med (1980) 1.18
Incidence of squamous neoplasia of the cervix and vagina in women exposed prenatally to diethylstilbestrol (United States). Cancer Causes Control (2001) 1.17
Lack of evidence for cancer due to use of metronidazole. N Engl J Med (1979) 1.16
Comparison of Dacron-tipped applicator and cytobrush for detection of chlamydial infections. J Clin Microbiol (1988) 1.15
Prenatal exposure to stilbestrol. A prospective comparison of exposed female offspring with unexposed controls. N Engl J Med (1975) 1.14
The American Joint Committee on Cancer. Criteria for prognostic factors and for an enhanced prognostic system. Cancer (1993) 1.13
Vaginal epithelial changes in young women enrolled in the National Cooperative Diethylstilbestrol Adenosis (DESAD) project. Obstet Gynecol (1979) 1.12
Surrogate anatomic/functional sites for evaluating cancer risk: an extension of the field effect. Clin Cancer Res (1999) 1.12
A survey of human papillomavirus 16 antibodies in patients with epithelial cancers. Eur J Cancer Prev (1998) 1.11
Cervical specimens collected in liquid buffer are suitable for both cytologic screening and ancillary human papillomavirus testing. Cancer (1997) 1.10
Vinblastine, cisplatin, cyclophosphamide, bleomycin, doxorubicin, and etoposide in the treatment of small cell carcinoma of the ovary. Cancer (1989) 1.08
Detection of Chlamydia trachomatis using consecutive endocervical swabs. Prevalence in asymptomatic female adolescents and women attending a sexually transmitted disease clinic. J Reprod Med (1986) 1.08
Validation of intermediate end points in cancer research. J Natl Cancer Inst (1990) 1.07
Unusual malignant epithelial tumors of the gallbladder. Semin Diagn Pathol (1996) 1.06
The histologic grading of cancer. Cancer (1995) 1.06
Cancer after exposure to metronidazole. Mayo Clin Proc (1988) 1.05
Cardiac involvement in glycogen storage disease III: morphologic and biochemical characterization with endomyocardial biopsy. Am J Cardiol (1984) 1.05
Epidemiologic determinants of seroreactivity to human papillomavirus (HPV) type 16 virus-like particles in cervical HPV-16 DNA-positive and-negative women. J Infect Dis (1996) 1.04
Risk factors for penile cancer: results from a case-control study in China. Int J Cancer (1991) 1.04
Continued follow-up of pregnancy outcomes in diethylstilbestrol-exposed offspring. Obstet Gynecol (2000) 1.04
Intestinal metaplasia of the gallbladder: a morphologic and immunocytochemical study. Hum Pathol (1986) 1.03
Correlation of umbilical cord blood haematopoietic stem and progenitor cell levels with birth weight: implications for a prenatal influence on cancer risk. Br J Cancer (2008) 1.02
Design and preliminary observations of National Cooperative Diethylstilbestrol Adenosis (DESAD) Project. Obstet Gynecol (1978) 1.02
Infertility among women exposed prenatally to diethylstilbestrol. Am J Epidemiol (2001) 1.01
The WHO Histological Classification of Tumors of the Gallbladder and Extrahepatic Bile Ducts. A commentary on the second edition. Cancer (1992) 1.01
Physical activity and risk of large bowel cancer in the Framingham Study. Cancer Res (1990) 1.00
Congenital malformations among offspring exposed in utero to progestins, Olmsted County, Minnesota, 1936-1974. Fertil Steril (1985) 1.00
Cryptorchism and maternal estrogen exposure. Am J Epidemiol (1984) 1.00
A case-control study of epithelial ovarian cancer. Am J Obstet Gynecol (1989) 1.00
Malignant mesothelioma following radiation exposure. J Clin Oncol (1983) 0.99
Human papillomavirus detection and p53 expression in clear-cell adenocarcinoma of the vagina and cervix. Obstet Gynecol (1994) 0.99
Medical treatment of urethral prolapse in children. Obstet Gynecol (1982) 0.98
An analysis of 346 cases of clear cell adenocarcinoma of the vagina and cervix with emphasis on recurrence and survival. Gynecol Oncol (1979) 0.98
Breast cancer in DES-exposed mothers: absence of association. Mayo Clin Proc (1980) 0.97